Webinar discussion

Decoding Genetics of Rare Neurodevelopmental Disorders: A Cohort Study Powered by the GenomeArc Horizon Platform

Webinar discussion

Horizon: A Platform That Enables Ultra-Fast Variant Interpretation to Aid Diagnosis and Therapeutic Intervention

Webinar discussion

Provide Comprehensive Bioinformatics Solution

Discover how to turn your genomic data to insights in minutes powered by our AI-driven platform, GenomeArc Horizon.

Webinar discussion

Accelerating Genomic Medicine!

Our genome analytics platform brings unprecedented insights for meaningful diagnosis.

Horizon Genomic Medicine Platform

Our Horizon genomic medicine platform is fully automated for whole genome variant interpretations and pathogenicity predictions. The platform provides rapid actionable insights integrating complex phenotype data.

The Horizon platform helps achieve high genetic diagnostic yield and can analyse, interpret and report causal variants in minutes. We use well-curated variant databases and natural language processing (NLP) to understand complex genetic phenotypes.

Horizon is Efficient, Scalable, and Fast

Faster Automated analysis

Faster Automated
Analysis

Automation is at the core of Horizon, as it seamlessly integrates large and phenotypic genome databases with genome variants.

Validated Prediction Algorithms

Validated Prediction
Algorithms

Our variant pathogenicity algorithms validate with high precision using population scaled multi-ethnic clinical genomics datasets.

Accurate OMICs Databases

Accurate OMICs
Databases

Horizon platform integrates transcriptomes, proteomes, and other OMICs databases to interpret coded and non-coded genomic variants.

Horizon Genomic Medicine Platform Features

  • SNV/Indel/SV and phenotype analytics in one intuitive platform
  • Automated ACMG guided variant pathogenicity predictions
  • Pan cancer germline and somatic variant analytics
  • Carrier screening and reporting for over 500 genetic diseases
  • Integrates clinical phenotypic data applying NLP
  • Fast variant analysis for routine and NICU/PICU cases
  • Proprietary clinical genetic databases
  • Intuitive platform for large sample sizes
  • Custom investigations of variants and automated reporting
  • Custom integrations of secondary clinical data
Learn more about Horizon
horizon

Horizon: Comprehensive Solution for Variant Interpretation

The Horizon platform provides rapid precision diagnostic interpretation for reporting genomic variants and providing actionable therapeutic interventive insights for rare genetic diseases.

Our innovative solutions extracts cryptic phenotypic details to integrate large genomic databases for reporting.

Know More

End to End Bioinformatics Solutions

For Cancer and Rare Genetic Diseases

Genome Data Processing:

  • Sequence Alignment and
  • Variant Calls

Genome Interpretation

horizon

Impact:

  • Enable Diagnosis
  • Enable Therapeutics
  • Research

Integrate Custom Phenotypic

Database or Software

Partners and Collaborations

Global alliance
Canada technology
canarie logo
neurogenbd logo
mu logo
ncu logo
mbru logo
nvidia logo

Research Publications

Genomic Insights from a Deeply Phenotyped Highly Consanguineous Neurodevelopmental Disorders Cohort

The genetic underpinning of neurodevelopmental disorders (NDDs) in diverse ethnic populations, especially those with high rates of consanguinity,

Neuronal SNCA transcription during Lewy body formation

Misfolded α-synuclein (α-syn) is believed to contribute to neurodegeneration in Lewy body disease (LBD) based on considerable evidence including a gene-dosage

Read More
DNA research

Latest Blogs

Decoding Genetics of Rare Neurodevelopmental Disorders: A Cohort Study Powered by the GenomeArc Horizon Platform

Neurodevelopmental disorders (NDDs) represent a complex web of genetic underpinnings, particularly in ethnically diverse populations with high rates of consanguinity...

Read More

GenomeArc Announces Early Access Program for Horizon Version 2, the Most Comprehensive Multi-Omics Platform for Clinical Genomics

GenomeArc, a pioneering force in genomic technology, is proud to announce the Early Access Program for Version 2 of its Clinical Genetics...

Read More

Horizon Intelligence: Transforming Genomic Diagnosis with Multi-OMICs AI

In the rapidly evolving field of genomics, the need for fast, accurate, and precise variant interpretation has never been greater. As the volume of...

Read More

Subscribe to the
GenomeArc Newsletter

We care about the protection of your data.

Meet Our Scientific Advisory Board

  • Mohammed Uddin (Dafil)
    PhD

    Associate Professor,
    College of Medicine, MBRU, Dubai
    Founder and CEO,
    GenomeArc Inc. Toronto, Canada

  • Marc Woodbury-Smith
    MD, PhD

    Senior Lecturer,
    Biosciences Institute, Newcastle University, Newcastle Upon Tyne, UK

  • Bakhrom K. Berdiev
    MD, PhD

    Associate Professor,
    College of Medicine,
    Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai

  • Proton Rahman
    MD, FRCPC, FCAHC

    Professor of Medicine,
    Faculty of Medicine,
    Memorial University, Canada

  • Wolfgang Kuebler
    MD, PhD

    Director,
    Institute of Physiology, Charité - Universitätsmedizin Berlin, Germany Professor, Associate Scientist,
    University of Toronto, Canada

The Team

We are a team of geneticist, clinicians, bioinformaticians, software engineers, and ethicists, committed to solving genetic diseases, to advance science and benefit humanity. Our research driven approach is helping us constantly updating and solving the most complex problems in genomic medicine.!

Find Us

We have global teams supporting customers worldwide and we are headquartered in the wonderful city of Mississauga, Ontario.

Postal address

GenomeArc Inc. 55 Village Centre Place, Mississauga, ON, L4Z 1V9, Canada

Request for Demo